Annual Net Income
-$583.20 M
-$166.63 M-40.00%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual net profit is -$583.20 million, with the most recent change of -$166.63 million (-40.00%) on December 31, 2023.
- During the last 3 years, IBRX annual net income has fallen by -$361.35 million (-162.88%).
- IBRX annual net income is now -269.63% below its all-time high of -$157.78 million, reached on December 31, 2019.
Performance
IBRX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$85.73 M
+$48.84 M+36.29%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly net profit is -$85.73 million, with the most recent change of +$48.84 million (+36.29%) on September 30, 2024.
- Over the past year, IBRX quarterly net income has increased by +$48.84 million (+36.29%).
- IBRX quarterly net income is now -131.46% below its all-time high of -$37.04 million, reached on March 31, 2020.
Performance
IBRX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$587.79 M
+$9.85 M+1.65%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM net profit is -$587.79 million, with the most recent change of +$9.85 million (+1.65%) on September 30, 2024.
- Over the past year, IBRX TTM net income has increased by +$9.85 million (+1.65%).
- IBRX TTM net income is now -1487.00% below its all-time high of -$37.04 million, reached on March 31, 2020.
Performance
IBRX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
IBRX Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -40.0% | +36.3% | +1.6% |
3 y3 years | -162.9% | +37.8% | -24.2% |
5 y5 years | -269.6% | +37.8% | -24.2% |
IBRX Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -68.2% | at low | at high | +63.3% | -69.5% | +2.2% |
5 y | 5-year | -269.6% | at low | -131.5% | +63.3% | -1487.0% | +2.2% |
alltime | all time | -269.6% | at low | -131.5% | +63.3% | -1487.0% | +2.2% |
ImmunityBio Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$85.73 M(-36.3%) | -$587.79 M(-1.6%) |
Jun 2024 | - | -$134.56 M(+0.3%) | -$597.65 M(-0.6%) |
Mar 2024 | - | -$134.11 M(-42.5%) | -$600.96 M(+3.0%) |
Dec 2023 | -$583.20 M(+40.0%) | -$233.39 M(+144.2%) | -$583.20 M(+27.3%) |
Sep 2023 | - | -$95.58 M(-30.7%) | -$458.02 M(-3.2%) |
Jun 2023 | - | -$137.88 M(+18.5%) | -$473.38 M(+10.1%) |
Mar 2023 | - | -$116.34 M(+7.5%) | -$430.08 M(+3.2%) |
Dec 2022 | -$416.57 M | -$108.22 M(-2.5%) | -$416.57 M(+4.2%) |
Sep 2022 | - | -$110.94 M(+17.3%) | -$399.61 M(+6.2%) |
Jun 2022 | - | -$94.59 M(-8.0%) | -$376.30 M(+1.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$102.83 M(+12.7%) | -$370.00 M(+6.7%) |
Dec 2021 | -$346.79 M(+56.3%) | -$91.26 M(+4.1%) | -$346.79 M(+7.3%) |
Sep 2021 | - | -$87.63 M(-0.7%) | -$323.30 M(+7.3%) |
Jun 2021 | - | -$88.29 M(+10.9%) | -$301.28 M(+13.9%) |
Mar 2021 | - | -$79.61 M(+17.5%) | -$264.43 M(+19.2%) |
Dec 2020 | -$221.85 M(+40.6%) | -$67.77 M(+3.3%) | -$221.85 M(+44.0%) |
Sep 2020 | - | -$65.60 M(+27.5%) | -$154.08 M(+74.1%) |
Jun 2020 | - | -$51.44 M(+38.9%) | -$88.48 M(+138.9%) |
Mar 2020 | - | -$37.04 M | -$37.04 M |
Dec 2019 | -$157.78 M | - | - |
FAQ
- What is ImmunityBio annual net profit?
- What is the all time high annual net income for ImmunityBio?
- What is ImmunityBio annual net income year-on-year change?
- What is ImmunityBio quarterly net profit?
- What is the all time high quarterly net income for ImmunityBio?
- What is ImmunityBio quarterly net income year-on-year change?
- What is ImmunityBio TTM net profit?
- What is the all time high TTM net income for ImmunityBio?
- What is ImmunityBio TTM net income year-on-year change?
What is ImmunityBio annual net profit?
The current annual net income of IBRX is -$583.20 M
What is the all time high annual net income for ImmunityBio?
ImmunityBio all-time high annual net profit is -$157.78 M
What is ImmunityBio annual net income year-on-year change?
Over the past year, IBRX annual net profit has changed by -$166.63 M (-40.00%)
What is ImmunityBio quarterly net profit?
The current quarterly net income of IBRX is -$85.73 M
What is the all time high quarterly net income for ImmunityBio?
ImmunityBio all-time high quarterly net profit is -$37.04 M
What is ImmunityBio quarterly net income year-on-year change?
Over the past year, IBRX quarterly net profit has changed by +$48.84 M (+36.29%)
What is ImmunityBio TTM net profit?
The current TTM net income of IBRX is -$587.79 M
What is the all time high TTM net income for ImmunityBio?
ImmunityBio all-time high TTM net profit is -$37.04 M
What is ImmunityBio TTM net income year-on-year change?
Over the past year, IBRX TTM net profit has changed by +$9.85 M (+1.65%)